Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis

BACKGROUND & AIMS: The use of non‐selective beta‐blockers has been associated with lower rates of infection and reduced infection‐associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA. METHODS...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Liver Int
Egile Nagusiak: Gimenez, Paula, Garcia‐Martinez, Irma, Francés, Rubén, Gonzalez‐Navajas, Jose M., Mauri, Montserrat, Alfayate, Rocío, Almenara, Susana, Miralles, Cayetano, Palazon, Jose M., Carnicer, Fernando, Pascual, Sonia, Such, José, Horga, José F., Zapater, Pedro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Cirrhosis and Liver Failure
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282820/
https://ncbi.nlm.nih.gov/pubmed/29802788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13890
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak